Dow Up 0.11% Nasdaq Up 0.50%

Immunomedics Inc. (IMMU)

-NasdaqGM
3.33 Up 0.13(4.06%) Aug 29, 4:00PM EDT
|After Hours : 3.33 Up 0.00 (0.01%) Aug 29, 4:45PM EDT
Prev Close:3.20
Open:3.20
Bid:3.10 x 300
Ask:3.50 x 7000
1y Target Est:7.00
Beta:0.71
Next Earnings Date:N/A
Day's Range:3.15 - 3.33
52wk Range:3.04 - 7.35
Volume:588,764
Avg Vol (3m):524,429
Market Cap:310.07M
P/E (ttm):N/A
EPS (ttm):-0.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMMU

Comparison

Symbol% ChgMkt Cap
IMMUUp 4.06%310.07M
BIIBUp 0.53%81.01B
GSKUp 0.47%117.94B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):32.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.48
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback